한국어
English
日本語
中文(简体)Beryplast-P Combi Set 1mL
Solution · Prescription medication · Combination
Korea Red Cross Society
Human plasma-derived coagulation factor XIII is used for the treatment of coagulation factor XIII deficiency.
MFDS ingredient code M255340
Human plasma-derived coagulation factor XIII is a protein that plays a critical role in the coagulation process. This component is used to prevent or treat bleeding in patients with coagulation factor XIII deficiency in the blood. Coagulation factor XIII helps to increase the stability of the thrombus after blood clotting.
Coagulation factor XIII cross-links fibrin fibers in the coagulation process, making the thrombus more robust. As a result, the thrombus at the site of bleeding does not easily break down, assisting in the cessation of bleeding. When supplemented in deficient patients, it restores normal blood coagulation function.
Approved uses differ by product. Check each product's information for its actual use.
Coagulation factor XIII specializes in maintaining the stability of the thrombus, unlike other coagulation factors. Unlike general coagulation factors, it acts in the later stages after thrombus formation, and deficiency is characterized by continued bleeding. Therefore, supplementation of coagulation factor XIII is only necessary for specific deficiency patients.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.